WHO just released the recommended composition for the 2024-2025 flu vaccine in the Northern Hemisphere. Developing vaccines based on this composition can help ensures effective flu protection for the upcoming flu season!
Explore our key reagents for influenza vaccine and drug development, aligned with the WHO recommendations!
Immobilized Influenza B [Austria/1359417/2021 (B/Victoria lineage)] Hemagglutinin (HA) Protein, His Tag (Cat. No. HAE-V52H3) at 1 μg/mL (100 μL/well) can bind various dilution ratio of Influenza B Hemagglutinin / HA Antibody, Rabbit Mab IgG (QC tested).
SPR
Influenza b Hemagglutinin/HA Antibody captured on Protein G-Series S sensor chip can bind Influenza B [Austria/1359417/2021 (B/Victoria lineage)] Hemagglutinin (HA) Protein, His Tag (Cat. No. HAE-V52H3) with an affinity constant of 0.337 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
